Head of Medical Affairs & CSPV - Fresenius Kabi
Uwe Gudat joined the pharmaceutical industry in 1995 with Eli Lilly and since then has held positions at Hesperion/Actelion, Novartis, Merck Serono and Fresenius-Kabi. He has led global clinical development teams, served as global medical brand director, provided clinical support to global in-licensing teams, conducted formal clinical trial design reviews, performed product safety assessments, and guided first in man transitions. Most recently he was Head of Safety, Biosimilars at Merck KGaA, then in Fresenius-Kabi after their acquisition of the biosimilars unit. In 2022 he will join a start-up providing clinical research education.
Subscribe today to receive news on latest updates,
offers and upcoming conferences via email
Follow us online to stay up to date about our conferences